BioAdaptives Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $150.1K | $-111.1K | $-823.3K | $-379.5K | $-157.9K | $-197.1K | $-371.8K | $-37.6K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $1.5K | $1.5K | $1.5K | $1.5K | $1.0K | $0 | — | — |
| Amortization | — | $0 | $0 | $0 | $-75.0K | $75.0K | $-18.0K | $0 |
| Stock-Based Compensation | — | — | — | — | $28.7K | — | — | — |
| Net Cash from Operating Activities | $-44.4K | $-84.8K | $-155.8K | $-151.3K | $-111.0K | $-97.9K | $-100.5K | $-56.3K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | — | — | — | — | — |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |